Salama, Abou Bakr M.
Abouleisa, Riham R. E.
Ou, Qinghui
Tang, Xian-Liang
Alhariry, Nashwah
Hassan, Sarah
Gebreil, Ahmad
Dastagir, Muzammil
Abdulwali, Fareeha
Bolli, Roberto
Mohamed, Tamer M. A.
Funding for this research was provided by:
NIH (HL-78825, R01HL147921, P30GM127607)
AHA (16SDG29950012)
Article History
Received: 12 July 2022
Accepted: 13 October 2022
First Online: 25 October 2022
Declarations
:
: TMAM holds equities in Tenaya Therapeutics. The other authors report no conflict.
: No animal studies were carried out by the authors for this article. Plasma and tissue samples were available from previous studies.